MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 162 filers reported holding MOMENTA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,025,000 | +44.3% | 38,600 | -8.5% | 0.01% | +33.3% |
| Q2 2020 | $1,403,000 | +18.1% | 42,200 | -3.4% | 0.01% | 0.0% |
| Q1 2020 | $1,188,000 | +560.0% | 43,700 | +252.4% | 0.01% | +500.0% |
| Q1 2019 | $180,000 | -38.8% | 12,400 | -53.6% | 0.00% | 0.0% |
| Q4 2018 | $294,000 | -58.1% | 26,700 | 0.0% | 0.00% | -66.7% |
| Q3 2018 | $702,000 | +28.6% | 26,700 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $546,000 | -45.5% | 26,700 | -51.6% | 0.00% | -50.0% |
| Q1 2018 | $1,001,000 | +28.7% | 55,200 | -1.1% | 0.00% | +33.3% |
| Q4 2017 | $778,000 | -24.6% | 55,800 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $1,032,000 | +15.4% | 55,800 | +5.5% | 0.00% | 0.0% |
| Q2 2017 | $894,000 | +304.5% | 52,900 | +218.7% | 0.00% | +300.0% |
| Q1 2017 | $221,000 | +52.4% | 16,600 | +5.1% | 0.00% | 0.0% |
| Q1 2016 | $145,000 | -73.7% | 15,800 | -57.5% | 0.00% | -50.0% |
| Q4 2015 | $552,000 | -3.2% | 37,200 | -23.9% | 0.00% | -33.3% |
| Q1 2014 | $570,000 | -88.4% | 48,900 | -82.3% | 0.00% | -86.4% |
| Q4 2013 | $4,896,000 | -18.0% | 276,918 | -33.3% | 0.02% | -15.4% |
| Q3 2013 | $5,972,000 | -4.4% | 415,008 | 0.0% | 0.03% | -3.7% |
| Q2 2013 | $6,250,000 | – | 415,008 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
| ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
| Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
| SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
| Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
| SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
| Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
| TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |